Insulet Corporation announced on 23 October it has received US Food and Drug Administration clearance for the Omnipod 5 App for iPhone, extending compatibility with its tubeless automated insulin delivery (AID) system beyond Android devices.
Insulet said that the Omnipod 5 App for iPhone will launch first with the DexCom, Inc. G6 continuous glucose monitoring system (CGM) integration, followed by a full market release...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?